GENITOURINARY CANCERS

Latest News

ECOG Score Predicts Survival Across Metastatic Prostate Cancer Settings
ECOG Score Predicts Survival Across Metastatic Prostate Cancer Settings

February 3rd 2024

While ECOG performance status proves crucial for predicting survival in patients with metastatic prostate cancer, its specific impact on mCSPC needs further investigation.

Subcutaneous Nivolumab Delivers Clinical Equipoise to Standard IV Dosing in ccRCC
Subcutaneous Nivolumab Delivers Clinical Equipoise to Standard IV Dosing in ccRCC

January 27th 2024

Adjuvant Pembrolizumab Notably Improves OS vs Placebo in ccRCC
Adjuvant Pembrolizumab Notably Improves OS vs Placebo in ccRCC

January 27th 2024

Adjuvant Nivolumab Falls Short of Disease-Free Survival End Point in Locally Advanced High-Risk RCC
Adjuvant Nivolumab Falls Short of Disease-Free Survival End Point in Locally Advanced High-Risk RCC

January 27th 2024

Real-World Data Show RCC Type and Tumor Stage Advises on Recurrence
Real-World Data Show RCC Type and Tumor Stage Advises on Recurrence

January 27th 2024

Video Series
Video Interviews
Podcasts

More News